MeSH term
Count | Antiretroviral Therapy, Highly Active/*economics | 4 |
Antiretroviral Therapy, Highly Active/economics | 4 |
Antiretroviral Therapy, Highly Active/*economics/*utilization | 1 |
Antiretroviral Therapy, Highly Active | 302 |
*Antiretroviral Therapy, Highly Active | 306 |
Antiretroviral Therapy, Highly Active/trends | 1 |
Antiretroviral Therapy, Highly Active/*standards | 1 |
Antiretroviral Therapy, Highly Active/*mortality | 1 |
Antiretroviral Therapy, Highly Active/utilization | 2 |
Antiretroviral Therapy, Highly Active/*methods | 31 |
Antiretroviral Therapy, Highly Active/*psychology | 6 |
Antiretroviral Therapy, Highly Active/mortality | 1 |
Antiretroviral Therapy, Highly Active/*trends | 2 |
Antiretroviral Therapy, Highly Active/*utilization | 4 |
*Antiretroviral Therapy, Highly Active/methods | 1 |
Antiretroviral Therapy, Highly Active/methods | 12 |
Antiretroviral Therapy, Highly Active/*methods/*psychology | 1 |
Antiretroviral Therapy, Highly Active/adverse effects | 18 |
*Antiretroviral Therapy, Highly Active/adverse effects | 11 |
Antiretroviral Therapy, Highly Active/*methods/utilization | 1 |
Antiretroviral Therapy, Highly Active/*standards/utilization | 1 |
Antiretroviral Therapy, Highly Active/*adverse effects | 27 |
Antiretroviral Therapy, Highly Active/*methods/standards | 1 |
*Antiretroviral Therapy, Highly Active/mortality/trends | 1 |
Antiretroviral Therapy, Highly Active/adverse effects/methods | 3 |
Antiretroviral Therapy, Highly Active/*statistics & numerical data | 2 |
*Antiretroviral Therapy, Highly Active/adverse effects/methods | 1 |
Antiretroviral Therapy, Highly Active/statistics & numerical data | 3 |
*Antiretroviral Therapy, Highly Active/statistics & numerical data | 1 |
Antiretroviral Therapy, Highly Active/*adverse effects/methods | 3 |
Antiretroviral Therapy, Highly Active/*adverse effects/utilization | 2 |
Antiretroviral Therapy, Highly Active/adverse effects/*methods | 5 |
Antiretroviral Therapy, Highly Active/statistics & numerical data/trends | 1 |
Diabetes Mellitus, Type 2/diet therapy/*drug therapy/economics | 1 |
Respiratory Therapy/economics | 1 |
HIV Infections/*economics/*therapy | 1 |
Hemophilia A/economics/*therapy | 1 |
Estrogen Replacement Therapy/*economics | 1 |
Pneumonia/*drug therapy/*economics | 1 |
HIV Infections/diagnosis/*economics/therapy | 1 |
HIV Infections/drug therapy/economics | 1 |
Fluid Therapy/economics/methods | 1 |
HIV Infections/economics/ethnology/*therapy | 1 |
HIV Infections/drug therapy/*economics | 1 |
Neoplasms/*economics/*psychology/therapy | 1 |
Influenza/economics/*immunology/*therapy | 1 |
Gene Therapy/economics/*methods | 1 |
*Neoplasms/diagnosis/economics/therapy | 11 |
Osteoarthritis/*economics/epidemiology/therapy | 2 |
HIV Infections/*drug therapy/economics | 1 |
Hematologic Neoplasms/economics/*therapy | 1 |
Lymphoma/economics/pathology/*therapy | 1 |
Affective Symptoms/economics/*therapy | 1 |
HIV Infections/*drug therapy/*economics | 1 |
Anemia/economics/etiology/*therapy | 1 |
Hypertension/*drug therapy/economics | 3 |
Cerebrovascular Disorders/economics/epidemiology/*therapy | 1 |
Kidney Failure, Chronic/economics/*therapy | 1 |
*HIV Infections/drug therapy/*economics/epidemiology | 1 |
Ovarian Neoplasms/*drug therapy/economics | 1 |
Staphylococcal Infections/drug therapy/economics | 1 |
HIV Infections/drug therapy/*economics/physiopathology | 1 |
Alzheimer Disease/economics/genetics/*therapy | 1 |
Asthma/*drug therapy/economics/pathology | 1 |
Malaria, Falciparum/*drug therapy/economics | 1 |
Diabetes Mellitus/*economics/physiopathology/therapy | 1 |
Skin Diseases/*classification/diagnosis/*economics/therapy | 9 |
Rhinitis, Allergic, Perennial/*economics/epidemiology/*therapy | 1 |
Diabetes Mellitus, Type 1/economics/*rehabilitation/*therapy | 1 |
HIV Infections/*diagnosis/drug therapy/economics/transmission | 2 |
Diabetic Nephropathies/drug therapy/*economics/physiopathology | 1 |
Neoplasm Recurrence, Local/drug therapy/economics | 1 |
Kidney Failure, Chronic/complications/economics/therapy | 1 |
Porphyria, Acute Intermittent/*drug therapy/economics | 1 |
HIV Infections/blood/*drug therapy/*economics/immunology | 1 |
HIV Infections/diagnosis/*drug therapy/*economics/ethnology | 1 |
Arthritis, Rheumatoid/drug therapy/economics/genetics | 1 |
Hepatitis C, Chronic/*drug therapy/*economics/mortality | 1 |
HIV Infections/*drug therapy/economics/immunology/mortality | 1 |
Heart Failure, Congestive/*drug therapy/*economics/epidemiology | 1 |
Kidney Failure, Chronic/complications/economics/*epidemiology/*therapy | 1 |
Heart Failure, Congestive/drug therapy/*economics/epidemiology | 1 |
Heart Failure, Congestive/*drug therapy/economics/epidemiology | 1 |
Kidney Failure, Chronic/*drug therapy/*economics/epidemiology | 1 |
Pulmonary Disease, Chronic Obstructive/diagnosis/economics/*therapy | 2 |
AIDS-Related Opportunistic Infections/drug therapy/economics | 1 |
Ventricular Dysfunction, Left/complications/drug therapy/economics | 1 |
Home Infusion Therapy/adverse effects/economics/*methods | 2 |
Heart Failure, Congestive/*drug therapy/*economics/etiology | 1 |
Lupus Erythematosus, Systemic/drug therapy/economics/genetics | 1 |
AIDS-Related Opportunistic Infections/*drug therapy/economics/mortality | 1 |
AIDS-Related Opportunistic Infections/*drug therapy/*economics/mortality | 1 |
Immunotherapy, Active | 13 |
Immunity, Active | 8 |
*Immunotherapy, Active | 25 |
*Immunity, Active | 3 |
Immunity, Active/*physiology | 1 |
Surface-Active Agents | 10 |
*Euthanasia, Active, Voluntary | 4 |
*Biological Transport, Active | 2 |
